Abstract
Purpose
The efficacy and safety of indomethacin (IM) oral spray (OS) as a pain control therapy for oropharyngeal mucositis due to anticancer chemo- and radiotherapy were assessed in patients with head and neck carcinomas and haematological tumours.
Method
We observed 35 patients (male/female, 20/15; 53 ± 17 years) with oropharyngeal mucositis who were treated with IM-OS preparation for pain relief at University of Tsukuba Hospital, Japan. Analgesic effects were assessed using the six-grade face scale for pain in 28 patients at the start of IM oral spray treatment. Systemic exposure was assessed by determining urinary excretions of IM in seven patients.
Results
Pain relief was achieved in 26 (93%) patients at 25 (5–60) min after applying the IM-OS preparation (15.6 ± 3.4 μg/kg) and analgesic effects were maintained for 120 (10–360) min. The pain was significantly decreased after using the spray (3.6 ± 0.7 vs. 2.4 ± 0.9, p < 0.01). Moreover, urinary IM excretion rates after applying the IM spray preparation were 1.8 ± 0.8% of the IM oral spray dose (130.5 ± 77.7 μg/kg/day), which was markedly lower than that following oral administration of IM (60%). No adverse events were observed following application of the spray.
Conclusions
The present IM spray is an effective and safe preparation for pain relief and can be used as an alternative therapeutic option for oropharyngeal mucositis in cancer patients.
This is a preview of subscription content, log in via an institution to check access.
References
Sangthawan D, Phungrassami T, Sinkitjarurnchai W (2013) A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients. J Med Assoc Thail 96:69–76
Nonzee NJ, Dandade NA, Patel U et al (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 113:1446–1452
Cheng KK, Leung SF, Thompson DR et al (2007) New measure of health-related quality of life for patients with oropharyngeal mucositis: development and preliminary psychometric evaluation. Cancer 109:2590–2599
Cheng KK, Leung SF, Liang RH, Tai JW, Yeung RM, Thompson DR (2009) A patient-reported outcome instrument to assess the impact of oropharyngeal mucositis on health-related quality of life: a longitudinal psychometric evaluation. Support Care Cancer 17:389–398
Yamagata K, Arai C, Sasaki H et al (2012) The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Bone Marrow Transplant 47:725–730
Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590–2598
Watanabe T, Ishihara M, Matsuura K, Mizuta K, Itoh Y (2010) Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. Int J Cancer 127:1984–1990
Shiratsuchi T, Makimura M, Furukawa T, Miwa H, Takezawa M, Kan Y (2000). Effect of local indomethacin solution on the stomatitis with in head and neck cancer patients. Jpn J Clin Res Death Dying 23: 98–103
Nakamura T, Aoyama T, Yanagihara Y et al (2003) The effects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic stem cell transplantation. Yakugaku Zasshi 123:1023–1029
Momo K, Shiratsuchi T, Taguchi H et al (2005) Preparation and clinical application of indomethacin gel for medical treatment of stomatitis. Yakugaku Zasshi 125:433–440
Ebina K, Kizawa Y, Homma M et al (2007) Indomethacin spray for radiation oral mucositis—a report of five cases. Palliative Care Research 2:301–305
Momo K, Homma M, Suzuki Y, Kambayashi Y, Kohda Y (2014) The stability of indomethacin-spray preparation for the pain control on stomatitis caused by chemo- and radio-therapy. J Pharm Sci Technol Jpn 74:211–216
Package inserts of Aconip®pap, http://www.info.pmda.go.jp/downfiles/ph/PDF/470004_2649719S1215_3_02.pdf (accessed December 18, 2013)
Interview form of IDOMETHINEKOWA®Gel, http://www.info.pmda.go.jp/go/interview/1/270072_2649719M1178_1_004_1F (accessed December 18, 2013)
Nielsen BN, Aagaard G, Henneberg SW, Schmiegelow K, Hansen SH, Rømsing J (2012) Topical morphine for oral mucositis in children: dose finding and absorption. J Pain Symptom Manag 44:117–123
Vayne-Bossert P, Escher M, de Vautibault CG et al (2010) Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded study. J Palliat Med 13:125–128
Cerchietti LC, Navigante AH, Körte MW et al (2003) Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105:265–273
Weinberg DS, Inturrisi CE, Reidenberg B et al (1988) Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 44:335–342
Clinical trial registration on UMIN-CTR web, ID: UMIN000017664, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000020450 (accessed March 26, 2017)
Acknowledgements
This work was supported by JSPS KAKENHI Grant Numbers 15K18916. The sponsor had no role in study design, data collection, data analysis, or data interpretation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Momo, K., Nagaoka, H., Kizawa, Y. et al. Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy. Support Care Cancer 25, 2997–3000 (2017). https://doi.org/10.1007/s00520-017-3817-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3817-2